Jeronimo Martins


JERONIMO’S ALL SET FOR THE NEXT LEAP! (ADD; 19% UPSIDE)

22/03/23 -" Summary: Despite near-term challenges, Jeronimo Martins remains one of the healthiest companies in the sector. Inflation and recession fears will continue to put pressure on the industry, but JMT's ..."

Pages
50
Language
English
Published on
22/03/23
You may also be interested by these reports :
09/05/24
Ahold Dehaize’s Q1 FY24 performance was stronger than the market had expected. Group revenue improved by 1.6% yoy, as both segments clocked positive ...

08/05/24
2Q23/24: Sales ok but EBITDA miss. FY23/24E outlook confirmed

03/05/24
There were no major surprises in Sainsbury’s FY23/24 preliminary results. Group lfl sales grew by 7.5% yoy (-10bp vs the consensus), once again led ...

30/04/24
Jeronimo Martins Q1 performance was slightly ahead of the market’s expectations. The Group’s revenue improved by 5.5% yoy (+190bp vs the consensus). ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO